FDA Adverse Event Injury Summary report: N

FORTIFY VR, DF-4 CONNECTOR

MDR report key: 4170233 · Received January 13, 2014

Report

Report Number
2938836-2014-02813
Event Type
Injury
Date Received
January 13, 2014
Date of Event
March 2, 2012
Manufacturer
ST. JUDE MEDICAL INC., CARDIAC RHYTHM MANAGEMENT D
Product Code
LWS
PMA / PMN Number
P910023
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

ALL INFORMATION PROVIDED BY MANUFACTURER, NO MEDWATCH FORM WAS RECEIVED. THIS HISTORICAL COMPLAINT IS BEING FILED AS PART OF A RETROSPECTIVE REVIEW OF COMPLAINT FILES IN RESPONSE TO A RECENT FDA INSPECTION. THERE IS NO CHANGE TO THE ACTUAL PERFORMANCE OF THE PRODUCT AND THIS REPORT ONLY REPRESENTS AN ENHANCEMENT TO THE REPORTING CRITERIA GOING FORWARD. THIS HISTORICAL COMPLAINT IS BEING FILED AS PART OF A RETROSPECTIVE REVIEW OF COMPLAINT FILES IN RESPONSE TO A RECENT FDA INSPECTION. THERE IS NO CHANGE TO THE ACTUAL PERFORMANCE OF THE PRODUCT AND THIS REPORT ONLY REPRESENTS AN ENHANCEMENT TO THE REPORTING CRITERIA GOING FORWARD.

Description of Event or Problem · 1

IT WAS REPORTED THAT A SYMPTOMATIC PATIENT SENT A MERLIN.NET REPORT TO A CLINIC WITH A DEVICE THAT WAS POST SENSED T WAVE OVERSENSING. THE PATIENT RECEIVED INAPPROPRIATE ATP AND HIGH VOLTAGE THERAPY. THE OVERSENSING WAS NOTED ON A STORED ELECTROGRAM. REPROGRAMMING CHANGES WERE RECOMMENDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
23709 FORTIFY VR, DF-4 CONNECTOR IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS ST. JUDE MEDICAL INC., CARDIAC RHYTHM MANAGEMENT D CD1231-40Q

Patients

Seq Age Sex Outcome Treatment
1 82 YR